• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Recent Industry Personnel News

Recent Industry Personnel News

August 15, 2007
CenterWatch Staff
  • Wilmington, N.C.-based contract research organization (CRO) PPD promoted Susan Atkinson to senior vice president for global statistics and data management. Her duties will include overseeing electronic data capture operations and informatics. Atkinson began at PPD in 1991 as a senior biostatistician and most recently led PPD’s U.S. biostatistics, programming and data management operations.

  • Whitehouse, N.J.-based pharmaceutical company Merck named David E. Kelley, M.D., as vice president of the company’s diabetes and obesity research franchise. His will lead the group's investigators in biomarker, experimental medicine and imaging activities to help optimize drugs through phase II clinical trials. Kelley spent 20 years at the University of Pittsburg studying insulin resistance and diabetes. He was most recently the director of the Obesity & Nutrition Research Center.
  • London-based CRO Chiltern International’s Patricia Lovell-Hoare, the company’s executive vice president of regulatory affairs, as been invited to become a Fellow at the Royal Society of Medicine. 
  • Gaithersburg, Mary.-based preclinical CRO Bridge Pharmaceuticals has restructured its executive management team after it hired Thomas Oakley as chief executive officer. Prior to joining Bridge, Oakley was founder and president of the consulting firm DTO Associates. Previously, he worked at the CRO Covance for nine years as global vice president of finance for its early stage group. Bridge also appointed Patrick Jeanmonod as chief financial officer and promoted Ronald Marler to chief scientific officer.
  • London-based CRO Premier Research appointed Chris Nowell vice president of clinical trial management for the company’s international division. Most recently, Nowell was director of project management at Quintiles. He also has held clinical posts at Bayer.
  • Cincinnati-based CRO Kendle appointed Thomas Smith, M.D., to vice president of medical affairs. He will lead the company’s global medical affairs organization in charge of the group’s medical directors who advise clients on protocol design, endpoint selection and inclusion/exclusion criteria. Smith was most recently a global medical director in that group. Prior to joining Kendle, he held various positions at Akros Pharma, Genzyme and Abbott.



Be sure to send your organization's latest personnel news via email to the editors at Clinical Trials Today!

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing